Table 3.
Factors Associated with Disability as Measured by IBD-DI
| Median difference in IBD-DI score | P-value | |
|---|---|---|
| Socio-demographic | ||
| Age | –0.032a | 0.670 |
| Female sex | –7.0 | 0.002 |
| Married/relationship | –1.0 | 0.700 |
| Crohn's & Colitis Australia membership | –1.5 | 0.730 |
| Tertiary IBD clinic management | –5.5 | <0.001 |
| Disease characteristics | ||
| Diagnosis greater than 5 years ago | –3.0 | 0.390 |
| UC diagnosis | 1.0 | 0.405 |
| Previous IBD related hospitalization | –4.5 | 0.010 |
| Previous surgery | –4.0 | 0.035 |
| Treatment modalities | ||
| 5-ASA | 0.5 | 0.500 |
| Immunomodulator | –1.0 | 0.450 |
| Steroids | –5.5 | 0.007 |
| Biologicals | 2.0 | 0.770 |
| Beliefs about medications | ||
| High concerns | –5.0 | <0.001 |
| Low necessity | 4.0 | 0.800 |
| Lack of acceptance | –7.5 | <0.001 |
| Medication related behavior | ||
| Non-adherence | –14.0 | <0.001 |
a
Rho.
IBD-DI, Inflammatory Bowel Diseases Disability Index; 5-ASA, 5-aminosalicylic acid.